Glucocorticoid levels in maternal and cord serum after prenatal betamethasone therapy to prevent respiratory distress syndrome

The Journal of Clinical Investigation
P L BallardR A Ballard

Abstract

Serum glucocorticoid levels were determined in 20 mothers and 43 premature infants who received prenatal betamethasone therapy for prevention of respiratory distress syndrome (RDS). Maternal betamethasone peaked at 75 microg cortisol equivalents per 100 ml 1 h after injection of 12 mg steroid and declined to half by 6 h. Betamethasone in cord blood was 14.3 microg cortisol equivalents per 100 ml at 1 h, decreased to a level of 4.7 at 20 h, and was not detected 2 days after a second dose at 24 h. After the second dose, the mean level of cortisol in cord blood was 5.9 microg per 100 ml compared with 13.05 microg per 100 ml (p less than 0.001) in untreated premature infants. The unbound glucocorticoid activity in treated infants delivered 1-10 h after the second dose (mean, 8.4 microg per 100 ml) is similar to the unbound cortisol level after birth in untreated premature infants who develop RDS. These findings indicate that (a) serum glucocorticoid levels in the physiologic stress range can induce lung maturation in the human and (b) antenatal treatment with this dose of betamethasone does not expose the human fetus to potentially harmful pharmacologic levels of steroid.

References

Aug 1, 1975·The Journal of Clinical Endocrinology and Metabolism·P L BallardJ D Baxter
Jan 16, 1975·The New England Journal of Medicine·M de Fencl, D Tulchinsky
Aug 1, 1968·Archives of Disease in Childhood·G HardieJ E Kench
Sep 1, 1972·Proceedings of the National Academy of Sciences of the United States of America·P L Ballard, R A Ballard
Jan 1, 1973·Biology of the Neonate·M GumbinasP Huttenlocher
Nov 1, 1972·The Journal of Pediatrics·I Z BeitinsC J Migeon
Oct 27, 1967·Science·D Y PereyR A Good
Feb 1, 1974·The Journal of Clinical Investigation·P L Ballard, R A Ballard
Apr 1, 1962·The Journal of Clinical Investigation·P DE MOORM DECLERCK-RASKIN

❮ Previous
Next ❯

Citations

Jul 3, 1978·European Journal of Pediatrics·M Obladen
Jan 1, 1983·European Journal of Clinical Pharmacology·M C PetersenR L Nation
Oct 1, 1980·European Journal of Clinical Pharmacology·M C PetersenW G McBride
Jan 1, 1986·Springer Seminars in Immunopathology·J Buyon, I Szer
Sep 1, 1996·Indian Journal of Pediatrics·V K Rehan
May 1, 1977·Journal of Steroid Biochemistry·P M Farrell
May 1, 1995·Obstetrics and Gynecology·A Azancot-BenistyP Madelenat
Jan 1, 1994·Molecular Aspects of Medicine·G Desoye, E Shafrir
Jan 1, 1980·Pharmacology & Therapeutics·B T Smith, W G Bogues
Sep 1, 1987·Early Human Development·Y Anlar, B Anlar
Jan 8, 2004·American Journal of Obstetrics and Gynecology·Timothy J M MossJohn P Newnham
Apr 1, 1977·The Journal of Pediatrics·R OsathanondhH W Taeusch
Aug 4, 1999·Obstetrics and Gynecology·W L HuangS A Dunlop
May 30, 2001·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·W L HuangS A Dunlop
Apr 25, 2001·Kidney International·L A OrtizM Baum
Apr 11, 2003·Clinical Obstetrics and Gynecology·Donald J DudleyPeter W Nathanielsz
Apr 11, 2003·Clinical Obstetrics and Gynecology·Kellie Murphy, Fariba Aghajafari
Mar 18, 2003·Current Opinion in Pediatrics·Michel BaumAlbert Quan
Dec 25, 2004·Obstetrical & Gynecological Survey·P J van Runnard HeimelH W Bruinse
Dec 1, 1993·Acta Paediatrica Japonica; Overseas Edition·A CohenS Zecca
Feb 12, 1998·Archives of Disease in Childhood. Fetal and Neonatal Edition·R BajoriaN M Fisk
Jan 9, 2004·Archives of Disease in Childhood. Fetal and Neonatal Edition·A E CurleyH L Halliday
Dec 14, 2011·American Journal of Physiology. Lung Cellular and Molecular Physiology·Elke KuypersSuhas G Kallapur
Jan 1, 1983·Journal of Perinatal Medicine·H VerderK Gildsig
Jan 1, 1987·Journal of Perinatal Medicine·J C Schellenberg, G C Liggins
Feb 18, 2014·Journal de gynécologie, obstétrique et biologie de la reproduction·F FuchsM-V Senat
Dec 28, 2010·Journal de gynécologie, obstétrique et biologie de la reproduction·O Thiebaugeorges, B Guyard-Boileau
May 28, 2014·Nature Reviews. Endocrinology·Vasilis G Moisiadis, Stephen G Matthews
Jan 15, 2004·The Journal of Pediatrics·Miguel Sáenz de PipaónPieter J J Sauer
Sep 12, 2003·Current Rheumatology Reports·Jill P Buyon, Deborah M Friedman
Nov 11, 2008·Reproductive Sciences·Julie M KesselIan M Bird
Jan 1, 1980·Pharmacology & Therapeutics·G Telegdy
Nov 20, 2009·The International Journal of Neuroscience·Martina Pitzer, Martin H Schmidt
Jun 28, 2006·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·David M HaasCara Olsen
Mar 4, 2014·Seminars in Perinatology·Benjamin S Bryner, George B Mychaliska
Feb 1, 1977·British Journal of Obstetrics and Gynaecology·A KauppilaJ Haapalahti
Dec 18, 2010·Diabetes & Metabolism·O Thiebaugeorges, B Guyard-Boileau
Dec 8, 2007·Seminars in Perinatology·Karin M Fuchs, Donald R Coustan
Aug 1, 1981·American Journal of Reproductive Immunology : AJRI·M R CaudleC A Singhas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.